VOENA, Claudia
 Distribuzione geografica
Continente #
NA - Nord America 2097
EU - Europa 1543
AS - Asia 643
AF - Africa 24
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 4317
Nazione #
US - Stati Uniti d'America 2068
CN - Cina 463
IT - Italia 315
SE - Svezia 214
IE - Irlanda 186
UA - Ucraina 145
DK - Danimarca 132
FR - Francia 124
DE - Germania 115
FI - Finlandia 94
AT - Austria 72
KR - Corea 66
GB - Regno Unito 43
PL - Polonia 36
VN - Vietnam 34
JP - Giappone 30
CA - Canada 27
SN - Senegal 24
BE - Belgio 17
ES - Italia 15
IN - India 12
TR - Turchia 12
RU - Federazione Russa 9
AU - Australia 8
TW - Taiwan 7
RO - Romania 6
HK - Hong Kong 5
NL - Olanda 5
PT - Portogallo 4
BY - Bielorussia 2
CH - Svizzera 2
GR - Grecia 2
LT - Lituania 2
MX - Messico 2
MY - Malesia 2
NO - Norvegia 2
SA - Arabia Saudita 2
TH - Thailandia 2
UZ - Uzbekistan 2
AM - Armenia 1
AR - Argentina 1
EU - Europa 1
ID - Indonesia 1
IL - Israele 1
KW - Kuwait 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MO - Macao, regione amministrativa speciale della Cina 1
Totale 4317
Città #
Chandler 368
Beijing 307
Ann Arbor 207
Dublin 186
Fairfield 146
Houston 146
Torino 137
Wilmington 102
Jacksonville 99
Villeurbanne 86
Nyköping 71
Vienna 71
Woodbridge 71
Medford 70
Ashburn 65
Princeton 61
Dearborn 60
Cambridge 54
Seattle 54
Fremont 44
Pisa 38
Warsaw 31
Boston 25
Shanghai 24
San Mateo 23
Redwood City 21
Dong Ket 20
Turin 20
Norwalk 19
Brussels 17
Boardman 15
Milan 15
Guangzhou 12
Chengdu 11
Hangzhou 11
Tokyo 11
Grafing 10
Nanjing 10
San Diego 10
Jülich 9
Toronto 9
Rome 8
Duncan 7
Hefei 6
Ottawa 6
Bologna 5
Düsseldorf 5
El Paso 5
Falls Church 5
Jinan 5
Lissone 5
Occimiano 5
Taipei 5
Verona 5
Wuhan 5
Baotou 4
Changsha 4
Hebei 4
Kunming 4
Lachine 4
Lanzhou 4
Mountain View 4
Munich 4
Nanchang 4
New York 4
Palermo 4
Phoenix 4
Raritan 4
Valdagno 4
Zhengzhou 4
Aurora 3
Berlin 3
Chongqing 3
Göttingen 3
Hull 3
Liverpool 3
Montréal 3
New Haven 3
Philadelphia 3
Saint Petersburg 3
Santa Monica 3
Silver Spring 3
Valencia 3
Varese 3
Xian 3
Amsterdam 2
Antalya 2
Buffalo 2
Central District 2
Chaoyang 2
Chennai 2
Chicago 2
Colmenar Viejo 2
Cuceglio 2
Freiburg 2
Fuzhou 2
Herndon 2
Istanbul 2
Kaigandori 2
Kuala Lumpur 2
Totale 2978
Nome #
Phosphatidylinositol 3-kinase δ blockade increases genomic instability in B cells 338
A theranostic approach based on the use of a dual boron/Gd agent to improve the efficacy of Boron Neutron Capture Therapy in the lung cancer treatment 332
p130Cas mediates the transforming properties of the anaplastic lymphoma kinase 228
Excess of NPM-ALK oncogenic signaling promotes cellular apoptosis and drug dependency 212
The anaplastic lymphoma kinase controls cell shape and growth of anaplastic large cell lymphoma through Cdc42 activation 209
Efficacy of a Cancer Vaccine against ALK-Rearranged Lung Tumors 177
Redundant and non-redundant roles for Cdc42 and Rac1 in lymphomas developed in NPM-ALK transgenic mice 167
Maternal immunization: New perspectives on its application against non-infectious related diseases in newborns 113
The EGFR family members sustain the neoplastic phenotype of ALK+ lung adenocarcinoma via EGR1. 107
The enzymatic activity of 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase is enhanced by NPM-ALK: new insights in ALK-mediated pathogenesis and the treatment of ALCL 95
Idiotype vaccination in human myeloma: generation of tumor-specific immune responses after high-dose chemotherapy. 93
Oncogenic ALK regulates EMT in non-small cell lung carcinoma through repression of the epithelial splicing regulatory protein 1 91
Wiskott–Aldrich syndrome protein (WASP) is a tumor suppressor in T cell lymphoma 87
Detection of circulating tumor cells in multiple myeloma by a PCR-based method. 86
Evidence for a bone marrow B cell transcribing malignant plasma cell VDJ joined to C mu sequence in immunoglobulin IgG and IgA secreting multiple myelomas 84
Involvement of Grb2 adaptor protein in nucleophosmin-anaplastic lymphoma kinase (NPM-ALK)-mediated signaling and anaplastic large cell lymphoma growth. 82
The mutation of N-ras oncogene does not involve myeloid and erythroid lineages in a case of multiple myeloma. 74
RhoA silencing reverts the resistance to doxorubicin in human colon cancer cells 71
Molecular monitoring of minimal residual disease in follicular and mantle cell non-Hodgkin's lymphomas treated with high-dose chemotherapy and peripheral blood progenitor cell autografting. 71
BRAF gene is not mutated in plasma cell leukemia and multiple myeloma 70
ALK-dependent control of hypoxia-inducible factors mediates tumor growth and metastasis 69
Detection of minimal residual disease by real-time PCR can be used as a surrogate marker to evaluate the graft-versus-myeloma effect after allogeneic stem cell transplantation. 67
Molecular purging of multiple myeloma cells by ex-vivo culture and retroviral transduction of mobilized-blood CD34+ cells 65
Clinical and molecular remission after allogeneic blood cell transplantation in a patient with mantle-cell lymphoma. 64
NPM-ALK oncogenic tyrosine kinase controls T-cell identity by transcriptional regulation and epigenetic silencing in lymphoma cells 64
A novel nested-PCR strategy for the detection of rearranged immunoglobulin heavy-chain genes in B cell tumors. 62
The tyrosine phosphatase Shp2 interacts with NPM-ALK and regulates anaplastic lymphoma cell growth and migration 59
High-dose sequential chemoradiotherapy in multiple myeloma: residual tumor cells are detectable in bone marrow and peripheral blood cell harvests and after autografting. 57
Development of a consensus IgH quantitative assay for the detection of minimal residual disease in Chronic Lymphocytic Leukemia using 3’-minor groove binder probes. 57
The anaplastic lymphoma kinase as an oncogene in solid tumors 55
Liposomal doxorubicin reverses drug-resistance by inhibiting P-glycoprotein in human cancer cells 52
PCR-detectable non-neoplastic Bcl-2/IgH rearrangements are common in normal subjects and cancer patients at diagnosis, but rare in subjects treated with chemotherapy. 52
The anaplastic lymphoma kinase in the pathogenesis of cancer 52
Advances in cancer immunology and cancer immunotherapy 52
Inactivation of tumor suppressor genes, p53 and Rb1, in plasma cell dyscrasias. 51
Tyrosine phosphatases regulate resistance to ALK inhibitors in ALK+ anaplastic large cell lymphoma 51
The battle against ALK resistance: successes and setbacks. 50
RHO Family GTPases in the Biology of Lymphoma 50
Epitope mapping of spontaneous autoantibodies to anaplastic lymphoma kinase (ALK) in non-small cell lung cancer 49
Modulation of doxorubicin resistance by the glucose 6-phosphate dehydrogenase activity 47
LIGHT/TNFSF14 Promotes Osteolytic Bone Metastases in Non-small Cell Lung Cancer Patients 47
Simple and Rapid InVivo Generation of Chromosomal Rearrangements using CRISPR/Cas9 Technology 45
Molecular and clinical remissions in multiple myeloma: role of autologous and allogeneic transplantation of hematopoietic cells. 44
Liposome-encapsulated doxorubicin reverses drug resistance by inhibiting P-glycoprotein in human cancer cells. 43
Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies. 43
Modulation of doxorubicin resistance by the glucose 6-phosphate dehydrogenase activity 41
Targeting hif-1α regulatory pathways as a strategy to hamper tumor-microenvironment interactions in cll 41
Molecular remission after myeloablative allogeneic stem cell transplantation predicts a better relapse-free survival in patients with multiple myeloma. 37
Mutational activation of N- and K-ras oncogenes in plasma cell dyscrasias. 36
The Tyrosine Phosphatase SHP2 Interacts with NPM-ALK and Regulates Anaplastic Lymphoma Cell Growth and Migration. 34
Maspin and mammaglobin genes are specific markers for RT-PCR detection of minimal residual disease in patients with breast cancer 33
Nonmyeloablative conditioning followed by hematopoietic cell allografting and donor lymphocyte infusions for patients with metastatic renal and breast cancer 33
Modeling lung cancer evolution and preclinical response by orthotopic mouse allografts 32
Qualitative and quantitative polymerase chain reaction detection of the residual myeloma cell contamination after positive selection of CD34+ cells with small- and large-scale Miltenyi cell sorting system. 29
Modulation of doxorubicin resistance by the glucose 6-phosphate dehydrogenase activity 27
Frequent mutations of FBXO11 highlight BCL6 as a therapeutic target in Burkitt lymphoma 27
Review: biological implications of oncogenic rearrangements in non-small cell lung cancer 5
Genomic Profiling Identifies Putative Pathogenic Alterations in NSCLC Brain Metastases 4
Totale 4513
Categoria #
all - tutte 7080
article - articoli 0
book - libri 0
conference - conferenze 282
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7362


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018472 0000 00 0111 2121152212
2018/2019400 453320 1728 5163 18398834
2019/2020790 19264872 67114 8555 107707057
2020/2021653 42486226 6631 4930 76985273
2021/2022780 41443350 2827 8940 3073173152
2022/2023786 12810527103 75248 1000 0000
Totale 4513